IBDEI35I ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,50316,1,4,0)
;;=4^E05.90
;;^UTILITY(U,$J,358.3,50316,2)
;;=^5002492
;;^UTILITY(U,$J,358.3,50317,0)
;;=E05.91^^193^2490^40
;;^UTILITY(U,$J,358.3,50317,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50317,1,3,0)
;;=3^Thyrotoxicosis,Unspec w/ Thyrotoxic Crisis/Storm
;;^UTILITY(U,$J,358.3,50317,1,4,0)
;;=4^E05.91
;;^UTILITY(U,$J,358.3,50317,2)
;;=^5002493
;;^UTILITY(U,$J,358.3,50318,0)
;;=E89.0^^193^2490^32
;;^UTILITY(U,$J,358.3,50318,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50318,1,3,0)
;;=3^Postprocedural Hypothyroidism
;;^UTILITY(U,$J,358.3,50318,1,4,0)
;;=4^E89.0
;;^UTILITY(U,$J,358.3,50318,2)
;;=^5003035
;;^UTILITY(U,$J,358.3,50319,0)
;;=E03.2^^193^2490^13
;;^UTILITY(U,$J,358.3,50319,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50319,1,3,0)
;;=3^Hypothyroidism d/t Meds/Oth Exogenous Substances
;;^UTILITY(U,$J,358.3,50319,1,4,0)
;;=4^E03.2
;;^UTILITY(U,$J,358.3,50319,2)
;;=^5002471
;;^UTILITY(U,$J,358.3,50320,0)
;;=E03.9^^193^2490^14
;;^UTILITY(U,$J,358.3,50320,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50320,1,3,0)
;;=3^Hypothyroidism,Unspec
;;^UTILITY(U,$J,358.3,50320,1,4,0)
;;=4^E03.9
;;^UTILITY(U,$J,358.3,50320,2)
;;=^5002476
;;^UTILITY(U,$J,358.3,50321,0)
;;=E06.0^^193^2490^36
;;^UTILITY(U,$J,358.3,50321,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50321,1,3,0)
;;=3^Thyroiditis,Acute
;;^UTILITY(U,$J,358.3,50321,1,4,0)
;;=4^E06.0
;;^UTILITY(U,$J,358.3,50321,2)
;;=^2692
;;^UTILITY(U,$J,358.3,50322,0)
;;=E06.1^^193^2490^37
;;^UTILITY(U,$J,358.3,50322,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50322,1,3,0)
;;=3^Thyroiditis,Subacute
;;^UTILITY(U,$J,358.3,50322,1,4,0)
;;=4^E06.1
;;^UTILITY(U,$J,358.3,50322,2)
;;=^119376
;;^UTILITY(U,$J,358.3,50323,0)
;;=C73.^^193^2490^19
;;^UTILITY(U,$J,358.3,50323,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50323,1,3,0)
;;=3^Malig Neop of Thyroid Gland
;;^UTILITY(U,$J,358.3,50323,1,4,0)
;;=4^C73.
;;^UTILITY(U,$J,358.3,50323,2)
;;=^267296
;;^UTILITY(U,$J,358.3,50324,0)
;;=E16.2^^193^2490^10
;;^UTILITY(U,$J,358.3,50324,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50324,1,3,0)
;;=3^Hypoglycemia,Unspec
;;^UTILITY(U,$J,358.3,50324,1,4,0)
;;=4^E16.2
;;^UTILITY(U,$J,358.3,50324,2)
;;=^5002708
;;^UTILITY(U,$J,358.3,50325,0)
;;=E20.0^^193^2490^15
;;^UTILITY(U,$J,358.3,50325,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50325,1,3,0)
;;=3^Idiopathic Hypoparathyroidism
;;^UTILITY(U,$J,358.3,50325,1,4,0)
;;=4^E20.0
;;^UTILITY(U,$J,358.3,50325,2)
;;=^5002712
;;^UTILITY(U,$J,358.3,50326,0)
;;=E20.9^^193^2490^11
;;^UTILITY(U,$J,358.3,50326,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50326,1,3,0)
;;=3^Hypoparathyroidism,Unspec
;;^UTILITY(U,$J,358.3,50326,1,4,0)
;;=4^E20.9
;;^UTILITY(U,$J,358.3,50326,2)
;;=^5002714
;;^UTILITY(U,$J,358.3,50327,0)
;;=E23.0^^193^2490^12
;;^UTILITY(U,$J,358.3,50327,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50327,1,3,0)
;;=3^Hypopituitarism
;;^UTILITY(U,$J,358.3,50327,1,4,0)
;;=4^E23.0
;;^UTILITY(U,$J,358.3,50327,2)
;;=^60685
;;^UTILITY(U,$J,358.3,50328,0)
;;=E27.1^^193^2490^34
;;^UTILITY(U,$J,358.3,50328,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50328,1,3,0)
;;=3^Primary Adrenocortical Insufficiency
;;^UTILITY(U,$J,358.3,50328,1,4,0)
;;=4^E27.1
;;^UTILITY(U,$J,358.3,50328,2)
;;=^5002740
;;^UTILITY(U,$J,358.3,50329,0)
;;=E27.2^^193^2490^1
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI35I 3773 printed Apr 09, 2024@21:45:48 Page 2
IBDEI35I ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,50316,1,4,0)
+2 ;;=4^E05.90
+3 ;;^UTILITY(U,$J,358.3,50316,2)
+4 ;;=^5002492
+5 ;;^UTILITY(U,$J,358.3,50317,0)
+6 ;;=E05.91^^193^2490^40
+7 ;;^UTILITY(U,$J,358.3,50317,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,50317,1,3,0)
+10 ;;=3^Thyrotoxicosis,Unspec w/ Thyrotoxic Crisis/Storm
+11 ;;^UTILITY(U,$J,358.3,50317,1,4,0)
+12 ;;=4^E05.91
+13 ;;^UTILITY(U,$J,358.3,50317,2)
+14 ;;=^5002493
+15 ;;^UTILITY(U,$J,358.3,50318,0)
+16 ;;=E89.0^^193^2490^32
+17 ;;^UTILITY(U,$J,358.3,50318,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,50318,1,3,0)
+20 ;;=3^Postprocedural Hypothyroidism
+21 ;;^UTILITY(U,$J,358.3,50318,1,4,0)
+22 ;;=4^E89.0
+23 ;;^UTILITY(U,$J,358.3,50318,2)
+24 ;;=^5003035
+25 ;;^UTILITY(U,$J,358.3,50319,0)
+26 ;;=E03.2^^193^2490^13
+27 ;;^UTILITY(U,$J,358.3,50319,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,50319,1,3,0)
+30 ;;=3^Hypothyroidism d/t Meds/Oth Exogenous Substances
+31 ;;^UTILITY(U,$J,358.3,50319,1,4,0)
+32 ;;=4^E03.2
+33 ;;^UTILITY(U,$J,358.3,50319,2)
+34 ;;=^5002471
+35 ;;^UTILITY(U,$J,358.3,50320,0)
+36 ;;=E03.9^^193^2490^14
+37 ;;^UTILITY(U,$J,358.3,50320,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,50320,1,3,0)
+40 ;;=3^Hypothyroidism,Unspec
+41 ;;^UTILITY(U,$J,358.3,50320,1,4,0)
+42 ;;=4^E03.9
+43 ;;^UTILITY(U,$J,358.3,50320,2)
+44 ;;=^5002476
+45 ;;^UTILITY(U,$J,358.3,50321,0)
+46 ;;=E06.0^^193^2490^36
+47 ;;^UTILITY(U,$J,358.3,50321,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,50321,1,3,0)
+50 ;;=3^Thyroiditis,Acute
+51 ;;^UTILITY(U,$J,358.3,50321,1,4,0)
+52 ;;=4^E06.0
+53 ;;^UTILITY(U,$J,358.3,50321,2)
+54 ;;=^2692
+55 ;;^UTILITY(U,$J,358.3,50322,0)
+56 ;;=E06.1^^193^2490^37
+57 ;;^UTILITY(U,$J,358.3,50322,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,50322,1,3,0)
+60 ;;=3^Thyroiditis,Subacute
+61 ;;^UTILITY(U,$J,358.3,50322,1,4,0)
+62 ;;=4^E06.1
+63 ;;^UTILITY(U,$J,358.3,50322,2)
+64 ;;=^119376
+65 ;;^UTILITY(U,$J,358.3,50323,0)
+66 ;;=C73.^^193^2490^19
+67 ;;^UTILITY(U,$J,358.3,50323,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,50323,1,3,0)
+70 ;;=3^Malig Neop of Thyroid Gland
+71 ;;^UTILITY(U,$J,358.3,50323,1,4,0)
+72 ;;=4^C73.
+73 ;;^UTILITY(U,$J,358.3,50323,2)
+74 ;;=^267296
+75 ;;^UTILITY(U,$J,358.3,50324,0)
+76 ;;=E16.2^^193^2490^10
+77 ;;^UTILITY(U,$J,358.3,50324,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,50324,1,3,0)
+80 ;;=3^Hypoglycemia,Unspec
+81 ;;^UTILITY(U,$J,358.3,50324,1,4,0)
+82 ;;=4^E16.2
+83 ;;^UTILITY(U,$J,358.3,50324,2)
+84 ;;=^5002708
+85 ;;^UTILITY(U,$J,358.3,50325,0)
+86 ;;=E20.0^^193^2490^15
+87 ;;^UTILITY(U,$J,358.3,50325,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,50325,1,3,0)
+90 ;;=3^Idiopathic Hypoparathyroidism
+91 ;;^UTILITY(U,$J,358.3,50325,1,4,0)
+92 ;;=4^E20.0
+93 ;;^UTILITY(U,$J,358.3,50325,2)
+94 ;;=^5002712
+95 ;;^UTILITY(U,$J,358.3,50326,0)
+96 ;;=E20.9^^193^2490^11
+97 ;;^UTILITY(U,$J,358.3,50326,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,50326,1,3,0)
+100 ;;=3^Hypoparathyroidism,Unspec
+101 ;;^UTILITY(U,$J,358.3,50326,1,4,0)
+102 ;;=4^E20.9
+103 ;;^UTILITY(U,$J,358.3,50326,2)
+104 ;;=^5002714
+105 ;;^UTILITY(U,$J,358.3,50327,0)
+106 ;;=E23.0^^193^2490^12
+107 ;;^UTILITY(U,$J,358.3,50327,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,50327,1,3,0)
+110 ;;=3^Hypopituitarism
+111 ;;^UTILITY(U,$J,358.3,50327,1,4,0)
+112 ;;=4^E23.0
+113 ;;^UTILITY(U,$J,358.3,50327,2)
+114 ;;=^60685
+115 ;;^UTILITY(U,$J,358.3,50328,0)
+116 ;;=E27.1^^193^2490^34
+117 ;;^UTILITY(U,$J,358.3,50328,1,0)
+118 ;;=^358.31IA^4^2
+119 ;;^UTILITY(U,$J,358.3,50328,1,3,0)
+120 ;;=3^Primary Adrenocortical Insufficiency
+121 ;;^UTILITY(U,$J,358.3,50328,1,4,0)
+122 ;;=4^E27.1
+123 ;;^UTILITY(U,$J,358.3,50328,2)
+124 ;;=^5002740
+125 ;;^UTILITY(U,$J,358.3,50329,0)
+126 ;;=E27.2^^193^2490^1
